Scholarlink

Background <p>Rheumatoid arthritis (RA) is marked by synovial inflammation, cartilage loss, and bone erosion, with macrophages playing a central role. Pyruvate carboxylase (PC), a mitochondrial enzyme, has been linked to inflammation, but its role in RA is unclear.</p> Methods <p>We investigated the effects of pharmacological PC inhibition with ZY-444 in a collagen antibody-induced arthritis (CAIA) mouse model and assessed disease severity, cytokine production, and histopathology. In vitro, PC expressions were analyzed in U937 cells, macrophages, and LPS-activated macrophages. Functional analysis of PC knockdown was evaluated using qRT-PCR, ELISA, Western blotting, and apoptosis assays.</p> Results <p>In CAIA mice, ZY-444 treatment significantly reduced clinical severity, joint inflammation, macrophage infiltration, and histological severity, with efficacy comparable to dexamethasone. ZY-444 suppressed TNF-α and IL-6 in joints and decreased serum IL-6. In vitro, PC expression increased during macrophage differentiation and activation, while PC knockdown markedly reduced cytokine expression and secretion. Mechanistically, PC deficiency attenuated mitogen-activated protein kinase (MAPK) phosphorylation, enhanced macrophage apoptosis, and upregulated HIF-1α expression.</p> Conclusions <p>PC regulates macrophage-driven inflammation in RA. Its inhibition alleviates disease pathology, supporting PC as a therapeutic target and ZY-444 as a potential repurposed anti-inflammatory agent.</p>

错误：搜索内容不能为空，请输入英文关键词
错误：关键词超出字数限制，请精简
高级检索

Inhibiting pyruvate carboxylase as a potential therapeutic strategy for alleviating rheumatoid arthritis

  • 期刊论文

  • 发表日期：

    2026年5月20日

查看全文
  • Szu-Wei Huang,
  • Hui-Chun Yu,
  • Hsien-Bin Huang,
  • Pin-Chen Chen,
  • Ming-Chi Lu

摘要

Background

Rheumatoid arthritis (RA) is marked by synovial inflammation, cartilage loss, and bone erosion, with macrophages playing a central role. Pyruvate carboxylase (PC), a mitochondrial enzyme, has been linked to inflammation, but its role in RA is unclear.

Methods

We investigated the effects of pharmacological PC inhibition with ZY-444 in a collagen antibody-induced arthritis (CAIA) mouse model and assessed disease severity, cytokine production, and histopathology. In vitro, PC expressions were analyzed in U937 cells, macrophages, and LPS-activated macrophages. Functional analysis of PC knockdown was evaluated using qRT-PCR, ELISA, Western blotting, and apoptosis assays.

Results

In CAIA mice, ZY-444 treatment significantly reduced clinical severity, joint inflammation, macrophage infiltration, and histological severity, with efficacy comparable to dexamethasone. ZY-444 suppressed TNF-α and IL-6 in joints and decreased serum IL-6. In vitro, PC expression increased during macrophage differentiation and activation, while PC knockdown markedly reduced cytokine expression and secretion. Mechanistically, PC deficiency attenuated mitogen-activated protein kinase (MAPK) phosphorylation, enhanced macrophage apoptosis, and upregulated HIF-1α expression.

Conclusions

PC regulates macrophage-driven inflammation in RA. Its inhibition alleviates disease pathology, supporting PC as a therapeutic target and ZY-444 as a potential repurposed anti-inflammatory agent.